Introduction PHYSIOLOGY
The detection, identification and quantification of glucose in blood has played a vital role in the diagnosis and management of patients suffering from disorders of carbohydrate metabolism and is one of the most frequently performed determinations in clinical chemistry.
Glucose is quantitatively the most abundant carbohydrate that exists in the circulation of mammals and serves as the principal fuel for peripheral tissues except during prolonged fasting. Thus maintenance of the blood glucose concentration is closely controlled and affected by many factors (Fig. 1) .
Glucose levels in the blood may be transiently increased as a result of the absorption of ingested glucose from the gut. The liver enzyme glucokinase facilitates the rapid removal of large quantities of glucose from the portal vein after a meal, preventing the renal threshold for glucose (approximately 10 mrnol/L) being exceeded and causing unnecessary glycosuria. Man is an intermittent feeder but uses glucose continuously and the liver is the major organ which prevents the blood glucose level falling in periods of fasting, by producing glucose from breakdown of stored glycogen or by synthesis from precursors such as lactate, pyruvate, glycerol and amino acids.
In addition to these metabolic processes, many hormones affect glucose homeostasis. It has long been appreciated that insulin is the glucose regulatory hormone; it suppresses glucose production, accelerates glucose utilisation and thus lowers the plasma glucose concentration. In contrast, despite a plethora of candidates, the precise physiological mechanisms that raise the plasma glucose concentration have not been clearly defined. However, the circulating hor-This paper was prepared at the invitation of the Analytical Methods Working Party of the Association of Clinical Biochemists. Correspondence: Dr J M Burrin mones glucagon, adrenaline, cortisol, growth hormone and noradrenaline are all potentially involved in this process. 1 
REFERENCE RANGES
In normal man regulatory mechanisms operate so that blood glucose concentrations are generally maintained within the range 2·5 to 7·3 mmol/L? Values outside this range are unusual in people under the age of 45 and may warrant further investigation. In older people (> 65 years) values of up to 10 mmol/L may be found.? Random blood glucose concentrations below 2·5 mmol/L in adults should always invite further investigation. Glucose levels are well maintained during prolonged fasting for the reasons outlined above, but may fall below 2·6 mrnol/L in normal premenopausal women and in children."
There is some evidence for seasonal variation in fasting plasma glucose levels. A study performed in 12 men exposed to temperatures ranging from -40°C to O°C showed that blood glucose levels are lowest at the higher temperature. 5 Another study performed in a more moderate climate showed a significant seasonal variation in fasting plasma glucose." There was a mean 0·6 rnmol/L difference between the highest levels in winter and the lowest levels in spring. The difference was consistent over a two year period, similar at all ages (range and seen in both men and women. There was no apparent correlation with obesity, diet or exercise. with at least one intervening value ""11·0. "" 7·0 mmol/L "" 8·0 "" 7·0 2h after glucose ",,11·0 mmol/L ",,11·0 ",,10·0 glycaemia is responsible for the majority of cases seen in clinical practice. Persistent or recurring hypoglycaemia in neonates may be caused by certain inborn errors of carbohydrate and amino acid metabolism in addition to the causes outlined for the adult above. For further information on the causes and treatment of hypoglycaemia in both the adult and the neonate the reader is referred to reviews bi Milner;'! Gale.P and Hughes and Davies.' In addition to blood glucose profiles and single random and fasting determinations, blood glucose may be measured as part of selected tests of carbohydrate metabolism. The oral glucose tolerance test (OGTT) is the most commonly used (and possibly over-used) test for establishing the diagnosis of diabetes mellitus. Recently several national groups have collaborated in an attempt to standardise the glucose load and establish a new set of criteria for the interpretation of the OGTT. The three groups, the National Diabetes Data group.l" the Euroeean Association for the Study of Diabetes, 5 and the World Health Organisation Expert Committee on Diabetes16 have all published recommendations, which although not identical have many important features in common. Their recommendations on glycaemic criteria for diagnosis of diabetes mellitus after a 75 g oral glucose load are summarised in Table  2 .
Venous
Capillary whole blood whole blood Venous plasma CLINICAL NEED Analyses of blood glucose are used to detect hyper-and hypo-glycaemia, both of which can result from a variety of different disorders, many of them of endocrine origin ( Table 1) . The commonest cause of hyperglycaemia is diabetes mellitus, and elderly patients may present in hyperosmolar non-ketotic coma with blood glucose levels as high as 60 rnmol/L, 7 Apart from diagnosis, serial blood glucose levels are required to monitor diabetics on treatment, and to detect and ultimately to prevent gestational hyperglycaemia which although not necessarily harmful to the mother, may be damaging to the foetus."
Hypoglycaemia may be due to either decreased production of glucose by the body or to increased utilisation. Hypoglycaemia associated with high levels of insulin may be caused by treatment with insulin or sulphonylureas, by insulinomas, and possibly by other tumours secreting insulin-like substances.
Hypoglycaemia in adults for reasons other than insulin excess is relatively rare, but may be caused by liver or kidney disease, drugs." or other endocrine disorders (Table 1) .
Alcohol-induced hypoglycaemia should be regarded as a separate case in that there is a specific biochemical reason for the hypoglycaemia (i.e. alcohol inhibits gluconeogenesis) and it occurs in normal as well as in diseased liver. However, the cause of hypoglycaemia is often multifactorial; thus alcohol consumption or exercise may precipitate it in insulin-treated diabetics, and malnutrition is an important factor in drug-induced hypoglycaemia.
Neonatal hypo glycaemia has been defined as a blood glucose concentration below 1·10 mmol/L in the pre-term or low birth weight infant; below 1·67 mrnol/L from birth to 72 hours' and below 2·22 rnol/L thereafter in , 10 the full-sized or full-term infant. In the neonate, transient asymptomatic hypo- 
Sample type and collection
Glucose may be measured in plasma, serum, whole blood or deproteinised samples and the values obtained will depend on the type of sample collected. Values in plasma are approximately 12-13% higher than in whole blood. This is because the water content of the erythrocytes (73%) is less than that of plasma (93%), and because glucose is freely diffusible between plasma and erythrocytes; the greater water content of plasma means that the glucose concentration is higher.
Venous samples, whether whole blood or plasma, tend to give slightly lower results than capillary samples. However, in fasting subjects the values in arterial, capillary and venous samples are for all practical purposes the same. It is only after meals when glucose uptake in the periphery may be rapid, that glucose levels in arterial (and capillary) samples can exceed those in venous samples by as much as 1·8 mrnol/L. This is particularly important in the interpretation of glucose tolerance tests. A table of comparable values for a range of plasma, whole blood, capillary and venous glucose levels can be found in Alberti and Skrabalo.!"
The concentration of glucose in any sample begins to decrease immediately after collection because of the glycolytic action of erythrocytes and leukocytes. Various methods are used to avoid or delay this loss including the addition of preservatives such as sodium fluoride, sodium oxalate and sodium iodoacetate. Some loss of glucose may still occur even when blood is collected into preservative. Other approaches require prompt separation of the cellular component after blood withdrawal. This removal of blood cells allows the measurement of glucose in plasma, which more accurately reflects the composition of extracellular fluids and is independent of haematocrit. However, results are controversial concerning the stability of glucose in plasma stored for long periods, and there is some evidence that a significant and progressive linear decrease in plasma glucose values occurs with storage even at -20°c. IH This trend to decrease is more evident with samples containing high glucose concentrations. In contrast, glucose has been reported as stable for up to one year when stored at -20°C in perchloric acid extracts of blood.l"
The choice of specimen may to some extent depend on the method used for analysis. Substances which interfere in chemical methods based on the reducing properties of glucose often occur in the erythrocytes, so that protein precipitates of whole blood provide the best sample. Similarly, the enzyme inhibitory action of substances present in the erythrocytes makes whole blood less desirable than serum or plasma for enzymatic methods.
The choice of specimen may also depend on the clinical situation in which the analysis is required. Capillary samples from the finger, ear lobe or heel may be taken to collect volumes of up to 200~L of blood. The sample may be placed directly into a protein precipitant so that
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no anticoagulant or preservative is required. Alternatively, heparinised capillary tubes may be used and centrifuged for plasma determination. Capillary blood sampling is particularly suitable for paediatric analyses and in glucose series to avoid frequent venepunctures. Venous samples may have to be taken when larger volumes of blood are required. Again the blood may be taken directly into a protein precipitant or mixed with heparin and a preservative for plasma preparation.
Recently methods for glucose determination using capillary blood samples on filter paper have been reported.j" 21 This sampling method offers a practical alternative for collecting samples from diabetic patients at home. The blood spots are stable at 4°C for up to 10 days if filter paper impregnated with boric acid is used.i For analysis, the blood spots are eluted into a protein precipitant and assayed by enzymatic methods.F One group has investigated the use of salivary glucose levels but found no significant correlation between the glucose concentrations in parotid fluid and venous blood. 23 Thus the possibility of diabetics monitoring their day-today control by non-invasive techniques is as yet remote.
Liquid phase chemistries
The first methods for the determination of blood glucose were described over 100 years ago, and many more methods have subsequently been proposed. Basically, glucose methods fall into two categories: chemical methods and enzymic methods. These two groups can in turn be broken down into many different categories; qualitative or quantitative; applicable to blood or urine; manual or automated; and the type of detection system employed.
CHEMICAL METHODS
The early carbohydrate chemists showed that glucose existed in several different forms in solution, the predominance of a particular form being a function of the pH and the solvent. In neutral or weakly acidic solution the predominant form is the hemiacetal structure referred to as a pyranose. Due to asymmetry of the ring structure, two forms are possible; an aqueous solution of o-glucose is an equilibrium mixture of approximately one third n-n-glucopyranose and two-thirds~-D-glucopyranose. The aldehyde form of glucose is highly unstable. and only small amounts are present in aqueous solution. The 1,2-enediol form is .found in D-FRUCTOSE FIG. 2. Standard formula of the epimers n-glucose, 0mannose and n-fructose with its common enediol form.
FERRIC-REDUCTION METHODS
In the Hagedorn-Jensen ferric-reduction method.j" glucose is oxidised by heating the sample at loo a C for 10 or 15 min with a known excess of potassium ferricyanide in a strong alkaline solution (sodium carbonate or potassium phosphate, pH 10·5). The yellow ferricyanide ions, Fe(CN)>-, are reduced to colourless ferrocyanide ions, Fe(CN)4-, and the unchanged alkaline conditions and is the reactive species in reducing tests for sugars. It is important to note that since glucose, fructose and mannose differ only in the second carbon atom they all form the same enediol (Fig. 2 ). The consequence of this is that any reaction involving the reactivity of the enediol form does not differentiate between glucose, fructose and mannose. This applies to all of the methods based on the reducing properties of glucose.
The enediol form of glucose is highly reactive and easily oxidised. For many years chemical tests for glucose utilised this property of the glucose molecule to reduce alkaline copper or iron salt solutions. Upon oxidation, many different products are formed depending on the pH, temperature, salt concentration and the nature of oxidant used. By standardising assay conditions, the colour change produced can be used as a quantitative measure of the glucose present. However, both ferric and cupric reduction methods measure the total reducing capacity of a solution and may thus be regarded as non-specific for glucose, since there are many other substances in both blood and urine which possess reducing properties. CHzOH potassium ferricyanide is quantitated by iodometric backtitration with sodium thiosulphate. The method is rapid and the titration accurate but the oxidation of glucose is variable, being dependent on a number of factors such as the pH and temperature of the reaction mixture, and reoxidation of ferrocyanide by atmospheric oxygen. The sample must be deproteinised with zinc sulphate as zinc ions are needed in the formation of the ferrocyanide complex which completes the oxidation reaction.P The method is not satifactory for the determination of glucose values above 19 mmol/L, because alkali decomposes excess glucose.i" The test must therefore be repeated with a lower volume of sample or an increased amount of ferricyanide if decolourisation of the reaction mixture occurs within 3 min.
Numerous modifications of the Hagedorn-Jensen method have been proposed including the direct spectrophotometric measurement of ferrocyanide;" the measurement of the colour produced when ferrocyanide reacts with phosphomolybdic acid 2H and the measurement of Prussian blue, formed when excess ferric ion is added to the reaction mixture.j" The method has been extensively used in automated continuous-flow systems because of the economy and simplicity of the reaction. Some criticism of this system has arisen since it measures the decreasing ferricyanide constituent rather than the formed ferrocyanide, and alternative methods have been reported which either measure the ferrocyanide directly at 237 nm,27 or measure the orange-brown complex formed when ferrocyanide reacts with molybdate.r" This latter procedure requires 0·2 mL of serum, operates at 40 samples per hour and measures glucose levels up to 27·7 mmoVL. The results obtained by this method were reported to be lower, by 0·2 mrnol/L, than those obtained with the conventional automated alkaline ferricyanide reduction procedure.
The Hagedorn-Jensen method is non-specific for glucose since ferricyanide oxidises many non-sugar substances and polysaccaride-like substances such as dextrins. Increased specificity is obtained in the Autoanalyzer'N method by dialysis of glucose from proteins and other interfering substances but values in uraemic plasma determined by this procedure are markedly higher than those determined by a glucose oxidase method.i'''
CUPRIC-REDUCTION METHODS
Methods for glucose based on alkaline cupric reduction include the Somogyi-Nelson methods, the Neocuproine method, the Shaffer-Hartmann method, and the methods of Folin-Wu and Benedict. The last three methods may now be regarded as obsolete with the development of current specific methods but are briefly included for historical interest, and because of their extensive use for urine glucose measurement in primary health care centres in developing countries.V The methods all employ the reduction of cupric ion (Cu 2+) by glucose in hot alkaline solution to cuprous ion (Cu+). In the Schaffer-Hartmann method, the cuprous ion formed is then reoxidised by iodine and the excess iodine determined by measurement with thiosulphate." In the Folin-Wu 32 and Benedicts methods the cuprous ion is reacted with ph osphomolybdate to form a blue complex, 'molybdenum blue'. These methods have lost favour because of their lack of specificity.
Before the advent of enzymic methods the Somogyi-Nelson method was considered the reference method for glucose. The method used the reaction of reduced cuprous ions with arsenomolybdate to form molybdenum blue and the colour formed was found to be more stable and gave higher sensitivity than that seen with phosphornolybdate, A zinc sulphate-barium hydroxide deproteinisation step was included which increased the specificity of the method by co-precipitating various interfering substances such as glutathione.P Tungstic acid has also been used with the Somogyi-Nelson method to prepare protein-free filtrates of serumr" The use of serum was claimed to eliminate many of the interferences and results were essentially the same as those of the glucose oxidase method, the reference range for serum glucose being 4·16-6·22 mmoUL (95% limits). The neocuproine method was developed as a very sensitive copper-reduction method suitable for analysing small quantities of whole blood or plasma.P The method uses a tungstic acid filtrate prepared from a 20 ILL blood sample. Neo-cuproine reacts with reduced cuprous ions to form an orange-red complex. This coloured complex is stable for 10 h at room temperature and the colour formed is 30 times as intense as that formed with phosphomolybdate. The method was found to give a high blank reading but this could be substantially reduced by replacing tartrate with glycine" or eliminating tartrate completely.V This method has been adapted to the Autoanalyzer and the Technicon SMA-12,® and gives good agreement with an Autoanalyzer ferricyanide procedure. 3M However, results with the automated neocuproine method were consistently found to give values 2-10% higher than other methods."
Both the ferric and cupric reduction methods are nonspecific and susceptible to positive errors caused by the presence of non-glucose reducing substances in blood. These substances include glutathione, creatinine, uric acid, ascorbic acid, other sugars such as lactose and fructose, and drugs.i'" These interferences may be reduced by co-precipitation with various protein precipitants or by the use of dialysis in the Autoanalyzer methods but values obtained are still higher than those seen with enzymic methods.
AROMATIC-AMINE CONDENSATION

METHOD
One chemical method which is relatively specific is the a-toluidine test. This method uses the property of glucose and other aldohexoses to condense with aromatic amines in hot acetic acid solution to give coloured glycosylamines.t" The method may be regarded as specific for glucose since other aldohexoses such as galactose and man nose do not normally occur in significant amounts in man. The method may be used with or without sample deproteinisation. Factors which may cause error in this method are the water content of the reaction mixture, sodium fluoride, haemoglobin and bilirubin."! Other important drawbacks to the original method were the inconvenience of using glacial acetic acid; poor stability of the colour produced; the variability of the results with different batches of reagents; and the limited life of the chromogenic reagent. It was found that under appropriate conditions many of these inconveniences could be avoided, eg the addition of thiourea and borate favourably influences colour stability. 42 Despite the corrosive nature of the acetic acid reagent, the method was adapted for use on the Autoanalyzer'S' and SMA 12160 Autoanalyzer. 44 The method has also been adapted for the Autoanalyzer using ethylene glycol instead of acetic acid. 45 There was minimal interference from creatinine, ascorbic acid, uric acid or haemolysis, but bilirubin and lipid caused significant elevation of the glucose results. The method has been advocated as simple, reliable, specific and inexpensive but a-toluidine is now classed as a carcinogenic reagent so that operation of this method presents a health hazard. ENZYMIC METHODS Several specific methods have been described for determining glucose in biological fluids. These have used either glucose oxidase, hexokinase or more recently glucose dehydrogenase.
GLUCOSE OXIDASE
Glucose oxidase (~-D-glucose: oxygen J-oxidoreductase EC 1.1.3.4) from Aspergillus niger oxidises glucose according to the following reaction:
The enzyme is highly specific for~-D-glucose but most commercial preparations contain different amounts of mutarotase (aldose-lepimerase EC 5.1.3.3) allowing the use of glucose oxidase for the determination of glucose in solutions containing an equilibrium mixture of the isomers. Other sugars such as mannose and 2-deoxY-D-glucose are oxidised by glucose oxidase but at greatly reduced rates. The glucose oxidase reaction may be used to determine glucose either manometrically or colorimetrically.
In manometric techniques glucose is determined by measuring the rate of oxygen consumption using a polarographic oxygen electrode. The addition of ethanol to the reagent causes hydrogen peroxide to be destroyed by catalase (H 2 0 2 : H 2 0 2 oxidoreductase EC 1.11.1.6) in the glucose oxidase without yielding oxygen. Iodide and molybdate are added to the enzyme reagent to carry the reaction to completion:
The method was initially used for the determination of glucose in deproteinised filtrates of whole blood, plasma or serum.t" but was subsequently modified to determine glucose levels directly in serum, plasma and urine.V A direct measure of the glucose level in a sample is provided by comparison of the maximum apparent rate of oxygen consumption with the rate obtained with a glucose standard. Results are obtainable within 20 s after addition of 0·1 mL of sample. The usual interferences associated with colorimetric glucose-oxidase procedures an; avoided by measuring oxygen consumption rather than hydrogen peroxide formation. However, whole blood samples are not suitable since viable cells utilise oxygen. The method is available to the laboratory in a manual or semi-automated form as the Beckman glucose analyser. The system has been shown to be suitable for estimating levels between 1·67 and 55·5 mmoUL. 48 The method is easy to perform, gives quick and accurate results and is particularly suitable for use in smaller laboratories or a diabetic clinic. 49 The production of hydrogen peroxide in the glucose oxidase reaction can also be measured, either by direct electrochemical oxidation, by coupling to a second electrochemical oxidation, or by coupling to a second electrochemically active species such as 1-. In the Clark peroxidesensitive glucose electrode, the H 2 0 2 is measured amperometrically by oxidation at +0·7V on a platinum electrode. 50 The enzyme is trapped in a polycarbonate membrane envelope. The machine, from the Yellow Springs Instrument Co. is linear up to 25 mmol/L, uses only 25 IJ-L of serum and has, it is claimed, a between-assay precision (CV) of 1%.
The manual accompanying the YSI analyser states that phenols interfere with the glucose readings and therefore if could be expected that paracetamol, salicylamide, isoniazid etc. will cause overestimation of glucose. According to the manual paracetamol at a concentration of 0·46 rnmol/L gives an interference equivalent to 0·25 mmoUL. In practice this interference was found to be even greater. Initial studies performed by adding pure paracetamol to serum samples showed that 1·0 mmoUL of paracetamol caused an apparent glucose increase of 1·4 mmoUL. 5 1 Other studies have suggested that paracetamol may interfere still more. 52, 53 It is thought that these substances do not affect the enzymes involved with the glucose analysis but that they are oxidised and give an electrochemical response. 54 The manufacturers have now responded by introducing a modified membrane which, they claim, reduces paracetamol interference. 55 In a comparison between a modified and an unmodified membrane this claim was upheld and no significant correlation between serum paracetamol concentration and plasma glucose concentration was found using the modified membrane. 56 It has also been reported that the glycolytic inhibitor sodium iodoacetate interferes with this method. 57 This interference by iodoacetate is enhanced in the presence of sodium fluoride.
The hydrogen peroxide formed in the glucose oxidase reaction may also be measured by colorimetric reactions. This is made possible through the use of a coupled enzyme system in which the H 2 0 2 formed is coupled via peroxidase to a chromogenic O 2 acceptor. The oxygen acceptors originally used were o-dianisidine'" and o-toluidine.V It has since been established that these substances are carcinogenic and alternative oxygen acceptors such as 3-methyl-1benzothiazolinone hydrazone (MBTH),60 2,2'-azino~al-(3-ethyT-benzthiazo-line )-6-sulphonate-(ABTS)61 and 4-aminophenazone 62 have been suggested. Of these three procedures, that described by Trinder in 1969 has perhaps received most attention.Y This method used a phosphotungstic acid solution containing phenol as the protein precipitant, with phenol and 4aminophenazone as the O 2 acceptor. A subsequent modification described the use of sulphonated 2,4-dichlorophenol and 4-aminophenazone as the oxygen acceptor. 63 This increased the sensitivity of the method such that a 0·05 mL blood sample could be used. The reagents are stable, non-toxic, cheap and readily available. The method may be automated using the Autoanalyzer I or the SMA 6160, is linear up to 25 mrnol/L and may be applied to serum or urine analysis."
The MBTH and ABTS methods have also been adapted to the Technicon Autoanalyzer and the SMA 12/60. Nl . 65, M These automated methods are suitable for the determination of glucose in serum, plasma, urine and CSF.
Many substances have been reported to interfere with the glucose oxidase/peroxidase colorimetric methods. The use of MBTH, ABTS or 4-aminophenazone as oxygen acceptors are reported to be subject to less interference than o-dianisidine or o-toluidine.I" Sulphonylureas interfere with glucose determinations by the ABTS method." but the effects of bilirubin, creatinine, urea and gross haemolysis are negligible.P" Oral hypoglycaemic agents do not interfere in the MBTH or Trinder method, nor is there interference from uric acid, creatinine, glutathione, or haemoglobin.f" There is however some interference from rnannose, xylose, galactose, ascorbic acid, and levodopa in these methods.P" b4 The intereference by ascorbic acid in test systems involving peroxidase has recently been exensively studied.P" 70 The ascorbic acid interferes by producing a lag time in colour development, this being particularly important when kinetic procedures are used."! With reversible indicators such as o-toluidine, no colour develops during the ascorbic acid lag time. The duration of the lag time is proportional to the ascorbic acid concentration, inversely proportional to the enzyme concentration, and is also affected by concentrations of hydrogen peroxide and o-toluidine. This interference can be eliminated by the addition of mercuric salts which rapidly oxidise ascorbic acid to dehydroascorbate.P" With oxidativelycoupled indicator systems such as MBTH, ascorbic acid eliminates the rate of colour development but does not abolish it. This effect is dependent on the reaction pH and the nature of the coupler used. However, it is possible to select fast couplers, such as chromotropic acid, that are highl 6 resistant to interference by ascorbic acid."
The luminol chemiluminescence reaction for hydrogen peroxide detection offers a more sensitive alternative (10-12 mol) to the colorimetric peroxidase detection methods. The H 2 0 2 generated in the glucose oxidase reaction oxidises luminol in strongly alkaline solution with the emission of light. This method has been used to determine glucose in serum and urine using continuousflow systems and glucose oxidase immobilised on Sepharose.F 73 The limit of detection for glucose is 2 x 10-8 M and the calibration curve is linear up to lO-4M . Although it provides a highly sensitive assay for glucose, the possible interference of substances in biological samples has not yet been fully investigated.
Hexokinase
Glucose may be determined using hexokinase (A TP: D-hexose-6-phosphotransferase EC 2.7.1.1.) and glucose-6-phosphate dehydrogenase (n-glucose-f-phosphate: NADP oxidoreductase EC 1.1.1.49). Both enzymes may be isolated from yeast. The determination proceeds according to the following reactions: n-Glucose + ATP ---> Glucose-fi-PO, + ADP Glucose-ti-PO, + NADP+ --->
6-phosphogluconate + NADPli + H+
The NADPH generated in the second step is proportional to the glucose present and may be measured by absorbance at 340 nm or by fluorescence at 456 nm. The hexokinase reaction is essentially irreversible. Various other sugars including n-fructose , n-rnannose, n-glucosamine and 2-deoxy-o-glucose are also phosphorylated by hexokinase. Of these, fructose and mannose which are competitive inhibitors of hexokinase are the most important. However, neither exert a significant influence on the phosphorylation step at concentrations normally occurring in biological fluids or in various disorders such as essential fructosuria or hereditary fructose intolerance.
The second step of the reaction involving the catalytic dehydrogenation by glucose-6-phosphate dehydrogenase (G6PDH) of the glucose-6-phosphate formed in the first reaction is responsible for the high specificity of the assay, other hexose or pentose esters being unreactive. The combined specificities of the two enzymes thus limit interference by other carbohydrates. This specificity has been responsible for the proposal that this method be adopted as the reference method for glucose.P" If either of the enzyme preparations contain traces of phosphoglucose isomerase, fructose or fructose-6phosphate in the sample will react slowly and cause falsely elevated results. Phosphate buffer should not be used in the assay procedure since it inhibits G6PDH.
Many other substances have been tested for interference with this method. Only mannose at 3000 mg/L and tetracycline at 100 mg/L (30-100 times the usual therapeutic concentration) are reported to have any effect. 68 • ?4 The method has been extensively investigated and evaluated in the United States for use as a national glucose reference rnethod.P The method is suitable for glucose measurement in urine, plasma, serum, CSF, capillary blood and deproteinised extracts of blood.
The assay was originally carried out as a manual end point spectrophotometric procedure" but automated continuous spectrophotometric" and fluorimetric'" techniques have been reported. The fluorescence method is at least 20 times as sensitive as the absorbance method, so that glucose may be determined in as little as 3 I-lL of serum or plasma." The method has also been adapted for end-point analysis on automated discrete analysers such as, zhe Dupont ACA,?9 the Union Carbide centrifugal~nalyser,!!O and the GEMSAEC fast analvse-~J . The hexokinase method may also be used as a kinetic assay. Although it is generally acknowledged that kinetic methods offer advantages of increased speed and decreased dependence on interfering side reactions, there is still a general reluctance to use kinetic methods for substrates because of the dependence of kinetic results on variables such as temperature, pH, reagent composition, enzyme activity and the possible presence of inhibitors and activators in samples. However, assay conditions have been established by which the hexokinase/G6PDH coupled reaction system can be used for the kinetic determination of glucose.Y With the development of parallel discrete analysers many of the conditions on which kinetic results depend are kept constant and analytical throughput for glucose measurement can match that of the continuos-flow analysers. Successful adaptations of the kinetic hexokinase method have been made to the LKB8600 reaction rate analyser.V the Perkin-Elmer model KA-150 kinetic analyser'" and the GEMSAEC centrifugal analyser. 81 Bioluminescent assays for glucose using the hexokinase procedure have also been described. These utilise the enzyme luciferase purified either from bacteria or the firefly light organ. The former may be used for the determination of NADPH generated in the G6PDH reaction: NADPH + FMN + H+ oxidoreductase,
Methods for glucose using this system have been described. MS. 86 Firefly luciferase may be used to measure A TP consumed in the hexokinase reaction: firefly AT iferi 0 luciferase P'
The sensitivity of this method for ATP has been reported to be as low as 0·1 fmol/L, enabling very small sample volumes to be used." Despite the extreme sensitivity of these luminescent assays, few have been adopted for routine use in the clinical chemistry laboratory. This may be due to the limited availability of reagents and kits, the lack of automated luminometers, and problems associated with the sampling of very small volumes.
Glucose dehydrogenase
The recent availability of glucose dehydrogenase (B-o-glucose: NAD oxidoreductase; EC 5.1.3.3.) from Bacillus megaterium, or B. cereus has provided another enzymic method for glucose.I" The enzyme is NAD dependent and has the advantage over the previously described enzymic methods in involving a single-reaction step: glucose
The NADH generated in the reaction may be measured directly at 340 nm. The enzyme is highly specific for B-o-glucose; NAD as coenzyme and mutarotase is included as an auxiliary enzyme to decrease the reaction time in the equilibrium assay. The method appears very suitable for the determination of glucose in body fluids since only o-xylose (at levels greater than 2 mmoVL) and man nose are reported as causing interference.P" Compounds such as uric acid, bilirubin and ascorbic acid do not interfere. 90 The method is available in the UK in kit form (Merckotest kit, cat. no. 25244, BDH Chemicals, Poole, Dorset, UK). According to the manufacturer's instructions the final absorbance can be read 5 min after the start of the reaction and the absorbance remains stable for 30 min. However, a recent report has suggested that maximum absorbance is reached at 15 min, independent of glucose concentration, and thereafter decreases linearly with time.?' This observed decrease in NADH 2 absorbance varied inversely with the glucose concentration and increased with temperature.
Kinetic assays using reaction-rate analysers'? or centrifugal analysers'?' 93 have been reported. Using a reaction rate analyser the method was found to be linear up to 55 mmoVL with a sample volume of 10-20 ul., Good correlations with both glucose oxidase and hexokinase methods have been reported.Y 93 A comparison of the performance of the three enzymic methods for filter paper glucose determination demonstrated the GDH method to be superior to GOD with respect to time course of reaction. The detection limit was lower and the within-batch precision better than either the GOD or the HK method. 22 
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Solid-phase chemistries The development of methods for measuring glucose is a unique example of the search for simple and specific methods of analysis. This progress has been further enhanced by the realisation that immobilisation of enzymes onto solid-phase carriers can further extend the value of these techniques.
The immobilisation of enzymes has brought four major benefits to the area of glucose analysis: (i) improved stability of the reagent enzyme; (ii) reduced use of expensive reagents; (iii) facilitated development of rapid glucose analyses; and (iv) allowed analyses to be performed in the doctor's office, in the ward or in the patient's home. In their tum these developments have played a major part in the rethinking of the approach to the clinical management of diabetes.
It has been known for some years that modification of an enzyme structure, as can occur with coupling to a solid phase, can significantly improve the stability of an enzyme. However it does not appear possible to predict the outcome of immobilisation, and immobilisation techniques must therefore be tailored to each individual enzyme.r" In a review of 50 immobilised enzyme systems, 30 species exhibited enhanced stability characteristics.95 Weetall 96 compared several immobilisation techniques for glucose oxidase and showed that certain supports gave significant improvement in enzyme stability. In addition to effects on stability the immobilisation process may also affect the kinetic characteristics of the enzyme; readers are referred to the text by Carr and Bowers'" for a full discussion of immobilisation techniques and their sequelae.
Immobilised enzymes have been employed in several ways. The first was in the development of the enzyme electrode." In many examples the enzyme is immobilised onto the electrode sensor using physical or chemical techniques. Physical immobilisation is less harmful to the enzyme; where chemical immobilisation has been employed a protein spacer molecule has been used to protect the enzymes." The enzyme may also be held as a thin film over the electrode surface by a membrane; this latter approach often yields a less stable system than the immoblised formY9 A potentiometric system was described in 1973 by Nagy et.al. lll O Thesyltem was base~'6n glucose oxidase and peroxidase immobilised onto an iodide electrode. fhpocai dfJn::;cs in iodide ion concentration reflected the hydrogen peroxide generated (and subsequently destroyed by the peroxidase). The enzymes in this system were stable for 30 days, compared with 40 h for a typical li~uid-membrane electrode system. Hirsch et al. 01 co-immobilised glucose oxidase and aldehyde dehydrogenase and found that one nylon tube reactor in a continuous-flow analyser system could be used for several thousand assays.
The electrode systems have combined the economic benefits of reagent stability with the design of so called 'stat analysers'. There are a variety of additional applications of immobilised enzymes where the benefits are purely economic. Thus the concept of immobilised enzymes was introduced to continuous-flow analysers to conserve costly enzymes. 102 In continuous-flow analysers the enzymes have been immobilised on the inner surface of lengths of nylon tube; these reactors have then been inserted into the conventional continuous flow analyser. S~stems using glucose oxidase, 103 hexokinase1 and glucose dehydrogenase'i" have all been described. Noy and Alberti'?" have extended this approach to in vivo monitoring by the use of a continuous flow sampling catheter connected to. the continuous flow analyser; the advantage of the immobilised enzyme system here is the ability to run for many hours at low cost. This approach has been further extended to use in a feedback control~stem employed as an artificial pancreas. 1 Enzymes have also been immobilised onto stirrers in single-tube discrete analyzers. lOS In addition to spectrophotometric detection of the reaction products, fluorescence monitcring'P? and luminescent monitoring'!" have also been described. The sensitivity and range of these alternative monitoring systems can be used to advantage by further reduction of enzyme usage; however this may be at the expense of precision because of the high sample dilution required.
In addition to electrochemical and photometric detection use has also been made of other physical changes that occur. Thus an enzymic glucose assay has been described with enthalpimetric detection of the end point. III Further detection systems are given in reference 94. It is clear that many diabetologists foresee the implantable glucose sensor linked with a feedback control system to an insulin or drug delivery system as a means of controlling a patiert's blood glucose. The analytical tech-nology that will facilitate this development will no doubt also find use in laboratory equipment. A variety of electrochemical devices have been proposed for this approach.l'"
Despite the considerable efforts expended on the development of enzyme electrodes and continuous-flow immobilised enzyme systems, this technology has found limited use in routine clinical biochemistry. The development has in effect been superseded and totally overshadowed by the development of so-called dry reagent chemistry systems. Indeed the concept of dry reagent chemistry systems is founded on experience with the measurement of glucose. Early systems were designed to detect glucose in urine; the approach has subsequently been extended to the measurement of glucose (and other analytes) in plasma and whole blood. The dry reagent carrier systems have now been supplemented by instrumentation capable of quantifying the colour change by reflectance photometry.
At present there are at least six companies marketing dry reagent chemistry systems availabli:for-the-measurement of glucose, reflecting the considerable developmental efforts of three manufacturers. In essence each of the reagent carrier systems comprises several components including: (i) a sample handling surface layer; (ii) a means of compartmentalising reagents; (iii) a reflective layer; and (iv) a support material (Fig. 3) . The reader is referred to recent reviews ll 3--116 which detail the basic principles of reagent carrier design, principles of reflectance photometry and the extent of the application of the technology.
The reagent layer in each of the examples contains all the reagents that are required for the measurement of glucose. The reagent layer can be part of a film matrix or it can be impregnated in a paper stri~matrix which is covered with a membrane. 1 5 The first dry reagent systems achieved quantification of blood glucose by comparison of the colour produced in the reagent pad with a colour chart. This type of test strip has been marketed for several years by Miles Laboratories (Ames Division) and by Boehringer Mannheim; the reagent strips are given different names in different countries. The performance of the test is similar in both cases, a drop of blood being left in contact with the reagent pad for a defined period of time-after removal of the blood and allowing colour development, the colour is compared with the chart. It has been suggested'!" that the stability of the final colour differs with these two products. Several reports on the performance of these systems have appeared. 118. 119 Given thorough training of the operator it is generally considered that satisfactory performance can be achieved within the analytical range of the system, which is limited however.
In an attempt to obtain greater sensitivity in quantification and a wider analytical range simple reflectance meters were developed. Several meters have become available and their performance has been reported. As is the case with visual inspection, after appropriate training it is possible to achieve analytical performance that meets the clinical need and in some cases is comparable with laboratory performance. 121 l- 122 The linear analytical range of these sytems is generally 2-20 rnmol/L for blood glucose.
A dual reagent pad system has also been developed in another effort to extend the analytical range. Thus it is now possible to quantify blood Measurement of blood glucose 337 glucose over the range 1·1--44·0rnmol/L with one reagent strip. Comparisons of performance have indicated that the two reagent pad system is capable of similar performance to that achieved with the reflectance meter system. 123. 124 The ability to use reagent strips alone or in combination with simple, compact reflectance meters has had a major impact on the management of diabetes. Consequently analysis of blood glucose is now becoming commonplace in clinics, on wards and in the patient's home. This has introduced many new issues to the provision of an analytical service. It is clear from initial experience of this proliferation of analytical facilities that training is of vital importance in the maintenance of good performance. Early surveys of performance have indicated errors in analyses of quality control materials or parallel sample studies and, furthermore, a worrying lack of awareness of the need to participate in formalised quality control arrangements and the attendant functions of education and maintenance. 120, 125. 126 Dry reagent carrier systems have also been developed for a variety of analytes with their complementary microprocessor-controlled reflectance photometers. It is envisaged that these systems might be used in the smaller laboratory, the doctor's office or on the ward. Glucose assays are available on three such systems; the chemistry is based on the use of glucose oxidase in each case.
The Seralyser® employs a reagent strip on a rigid support. The system is suitable for use with a measured amount of diluted serum. The microprocessor-controlled photometer unit employs a xenon flash-light source and interference filters with a spherical detector for collecting reflected light. The system requires two-point calibration and results are available in less than 4 min. In an evaluation by Clarke and Broughton 127 the results compared with an automated glucose oxidase method yielded regression parameters y = 0'86x + 0·49, r = 0·98 (n = 1(0). Thomas et al. 12K achieved a between-batch precision of less than 5% over a serum glucose range 4·1-19·6 rnmol/L with excellent correlation of results with a hexokinase method.
The Ektachem system developed by Eastman Kodak offers a slightly different approach in that each reagent unit consists of several layers of film similar to photographic film. The system has been described in detail elsewhere. 129, 1311 The reagent carrier system is put of an automated instrument capable of measuring several analytes. The instrument pipettes the serum sample onto a film unit, incubates, and quantifies the colour produced by reflectance photometry.
Several reports of the Ektachem glucose system have appeared in the literature. [131] [132] [133] In an early model of the system Cate et al. 131 found excellent agreement of results with established analytical systems, and a day-to-day precision of less than 3%. Calibration of the system appeared to be stable over at least a week. The slides of reagents were shown to be very stable when kept in the refrigerator. Similar experience was reported by Kadinger and O'Kell. 132 In a multicentre trial Burnett et al. 133 reported good agreement of results with glucose oxidase and hexokinase methods; in a total of 20 sets of data the slope of the individual regression lines varied from 0·9 to 1·0.
The latest instrument to be released that is designed to handle different chemistries on a common reagent carrier is the Reflotron® (Boehringer Mannheim). This is the only multianalyte dry reagent system that uses whole blood.P" There are very significant developments in this system. Firstly, the reagent pad contains an upper layer which traps the red cells allowing the plasma to diffuse into a pad below and to the side. Secondly, the reagent is held in leaves of a gauze-type matrix which can be pressed down on the exposed plasmaimpregnated strip to the side of the red cells thus initiating the reaction; the instrument brings about this step at the appropriate time. The third, and perhaps most important, feature is that the reagent system and the response of the system can be so determined that with appropriate programming of the reflectance photometer, a calibrant sample is not necessary. The information to programme the photometer is contained in a magnetic strip on the underside of the carrier and is assimilated by the instrument on insertion of the strip. There is little data yet available on the performance of this system. 116 
Conclusions
The tremendous increase in the number of methods available for glucose determination in the last decade has perhaps deterred authors from writing reviews of glucose methodology and few have appeared since Cooper's review in 1973. 25 More commonly, one is referred to text~('''k~··'i," "etails of glucose methods.
Inevitably numerous publications are available on method comparisons. These have compared enzymic with colorimetric procedures,6ll. 135 kinetic with equilibrium techniques, 11M. 136 or the effects of instrumental adaptations to one particular rnethod.P" The reader is referred to these articles for the relative performance of glucose methods. Some generalisations are apparent such as the increased specificity of enzymic methods compared to chemical methods. However, factors other than accuracy may have to be considered by those confronted with the problem of choosing the 'best' method for their laboratory. The choice of method may be dependent on the clinical requirements, the type and number of specimens or the facilities available.
Of the solution chemistries, the glucose dehydrogenase methods combine the considerable advantages of simplicity, specificity and speed. The widespread acceptance of this relatively new method by routine laboratories for the determination of large number of samples is at present limited only by the cost of the reagents. However, glucose dehydrogenase has a larger turnover number than hexokinase or glucose oxidase and consequently may prove to be of even greater value in solid-state glucose sensors in the future.
For stat chemistry or the smaller laboratory, glucose oxidase linked to an electrode bypasses most of the interference associated with the lack of specificity of this method and gives rapid results. Dry chemistry reagent strips may also be of value in this situation since in the laboratory they have been shown to give comparable performance. Little information is available on their specificity and they may be subject to the same non-specific interferences as the solution glucose oxidase methods; in this respect one might expect interference to be more severe as the sample itself is the solvent and the relative concentration of interferents is greater therefore.
Colorimetric procedures may retain their place only in situations such as primary health care centres where reagent stability and cost are major factors; even here the dry chemistry reagent strips may offer greater advantages.
